GGrantIndex
← Leaderboards

Marta Filizola

Icahn School Of Medicine At Mount Sinai

$11,220,258
Attributed
$11,882,870
Total exposure
14
Grants
13
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.1M · FY200525
$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$11,882,870 · 14

By mechanism

R01$7,982,190 · 5
R21$2,654,854 · 4
K02$1,242,395 · 1
P41$3,431 · 4

Top collaborators

Most similar at Icahn School Of Medicine At Mount Sinai

Same institution · by research overlap

Research focus

G-Protein-Coupled ReceptorsStructureReceptorBaseLigandsInsightCollaborationsSignal TransductionReceptor FunctionMolecularAgonistOpioid ReceptorPharmaceutical PreparationsResearch StudyMolecular DynamicsOpioidLigand BindingDesignResolutionDrug AbuseHomoDimerizationMolecular ModelingDimer

Grant awards (49)

Leveraging Integrative Modeling and AI-Based Tools to Develop Safer Opioids$767,506
R01 · FY2025 · DA · contact PI
AI-Accelerated Discovery of Novel Compounds for GPCRs Targeted by Drugs of Abuse$211,250
R21 · FY2025 · DA · contact PI
AI-Accelerated Discovery of Novel Compounds for GPCRs Targeted by Drugs of Abuse$253,500
R21 · FY2024 · DA · contact PI
Molecular and Dynamic Insights into the Function of GPCRs Involved in Drug Abuse$381,375
R01 · FY2022 · DA · contact PI
Molecular and Dynamic Insights into the Function of GPCRs Involved in Drug Abuse$550,817
R01 · FY2021 · DA · contact PI
Molecular and Dynamic Insights into the Function of GPCRs Involved in Drug Abuse$381,376
R01 · FY2020 · DA · contact PI
A Structure-based Drug Discovery Effort to Combat COVID-19 and Future Outbreaks$169,420
R01 · FY2020 · DA · contact PI
Molecular and Dynamic Insights into the Function of GPCRs Involved in Drug Abuse$381,375
R01 · FY2019 · DA · contact PI
Biophysical approaches to investigate the biological significance of GPCR dimers$338,757
R01 · FY2019 · DA · contact PI
Molecular and Dynamic Insights into the Function of GPCRs Involved in Drug Abuse$361,985
R01 · FY2018 · DA · contact PI
Biophysical approaches to investigate the biological significance of GPCR dimers$338,757
R01 · FY2018 · DA · contact PI
Structural Aspects of Oligomerization in the Function of GPCRs$124,416
K02 · FY2018 · DA · contact PI
Biophysical approaches to investigate the biological significance of GPCR dimers$324,112
R01 · FY2017 · DA · contact PI
Enhanced Molecular Dynamics Methods to Investigate GPCR Ligand Binding$211,875
R21 · FY2017 · MH · contact PI
Structural Aspects of Oligomerization in the Function of GPCRs$124,416
K02 · FY2017 · DA · contact PI
Dynamic Mechanisms of GPCRs Targeted by Drugs of Abuse$377,561
R01 · FY2016 · DA · contact PI
Biophysical approaches to investigate the biological significance of GPCR dimers$320,869
R01 · FY2016 · DA · contact PI
Enhanced Molecular Dynamics Methods to Investigate GPCR Ligand Binding$254,250
R21 · FY2016 · MH · contact PI
Structural Aspects of Oligomerization in the Function of GPCRs$124,416
K02 · FY2016 · DA · contact PI
Dynamic Mechanisms of GPCRs Targeted by Drugs of Abuse$375,654
R01 · FY2015 · DA · contact PI
Biophysical approaches to investigate the biological significance of GPCR dimers$341,487
R01 · FY2015 · DA · contact PI
Structural Aspects of Oligomerization in the Function of GPCRs$124,416
K02 · FY2015 · DA · contact PI
Dynamic Mechanisms of GPCRs Targeted by Drugs of Abuse$381,375
R01 · FY2014 · DA · contact PI
Structural Aspects of Oligomerization in the Function of GPCRs$124,416
K02 · FY2014 · DA · contact PI
Dynamic Mechanisms of GPCRs Targeted by Drugs of Abuse$360,716
R01 · FY2013 · DA · contact PI
Structural Aspects of Oligomerization in the Function of GPCRs$124,542
K02 · FY2013 · DA · contact PI
Dynamic Mechanisms of GPCRs Targeted by Drugs of Abuse$343,238
R01 · FY2012 · DA · contact PI
Structural Aspects of Oligomerization in the Function of GPCRs$124,542
K02 · FY2012 · DA · contact PI
Efficiency of Enhanced Sampling Methods in GPCR Research$167,805
R21 · FY2011 · MH · contact PI
Structural Aspects of Oligomerization in the Function of GPCRs$124,542
K02 · FY2011 · DA · contact PI
MECHANISTIC INSIGHTS INTO THE ?INSIDE-OUT? SIGNALING OF INTEGRINS$1,094
P41 · FY2011 · RR · contact PI
OPIOID RECEPTOR OLIGOMERIZATION: PREDICTION & VALIDATION$282,904
R01 · FY2010 · DA · contact PI
Efficiency of Enhanced Sampling Methods in GPCR Research$209,095
R21 · FY2010 · MH · contact PI
Structural Aspects of Oligomerization in the Function of GPCRs$123,731
K02 · FY2010 · DA · contact PI
INFORMATICS OF GPCR DIMERS IN DRUG ABUSE MECHANISMS$351,242
R21 · FY2009 · DA · contact PI
OPIOID RECEPTOR OLIGOMERIZATION: PREDICTION & VALIDATION$284,422
R01 · FY2009 · DA · contact PI
Structural Aspects of Oligomerization in the Function of GPCRs$122,958
K02 · FY2009 · DA · contact PI
INFORMATICS OF GPCR DIMERS IN DRUG ABUSE MECHANISMS$351,242
R21 · FY2008 · DA · contact PI
OPIOID RECEPTOR OLIGOMERIZATION: PREDICTION & VALIDATION$283,122
R01 · FY2008 · DA · contact PI
INFORMATICS OF GPCR DIMERS IN DRUG ABUSE MECHANISMS$265,192
R21 · FY2007 · DA · contact PI
OPIOID RECEPTOR OLIGOMERIZATION: PREDICTION & VALIDATION$209,125
R01 · FY2007 · DA · contact PI
OPIOID RECEPTOR OLIGOMERIZATION: PREDICTION & VALIDATION$100,515
R01 · FY2007 · DA · contact PI
INFORMATICS OF GPCR DIMERS IN DRUG ABUSE MECHANISMS$89,351
R21 · FY2007 · DA · contact PI
STRUCTURAL STUDIES OF G-PROTEIN COUPLED RECEPTORS DIMERS USING DISCRETE REPRESE$297
P41 · FY2007 · RR · contact PI
OPIOID RECEPTOR OLIGOMERIZATION: PREDICTION & VALIDATION$325,722
R01 · FY2006 · DA · contact PI
INFORMATICS OF GPCR DIMERS IN DRUG ABUSE MECHANISMS$164,052
R21 · FY2006 · DA · contact PI
STRUCTURAL STUDIES OF G-PROTEIN COUPLED RECEPTORS DIMERS USING DISCRETE REPRESE$1,012
P41 · FY2006 · RR · contact PI
INFORMATICS OF GPCR DIMERS IN DRUG ABUSE MECHANISMS$126,000
R21 · FY2005 · DA
STRUCTURAL STUDIES OF G-PROTEIN COUPLED RECEPTORS DIMERS USING DISCRETE REPRESE$1,028
P41 · FY2005 · RR